INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)

$1.7 -0.072 (-4.0632%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 57

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) News Sources

Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

06-11-2025

yahoo.com

external link

Innate Pharma Receives US FDA Clearance to Begin Phase 3 Trial of Potential Skin Cancer Therapy

10-11-2025

yahoo.com

external link

Mycosis Fungoides Market Set to Expand by 2034 with Advancements in Targeted and Immunotherapy Approaches | DelveInsight

26-11-2025

yahoo.com

external link

Innate Pharma Q4 Earnings Call Highlights

26-03-2026

marketbeat.com

external link

Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ...

26-03-2026

yahoo.com

external link

How Innate Pharma (ENXTPA:IPH) Story Is Shifting Around 2026 Catalysts And €8 Target

27-03-2026

yahoo.com

external link

Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight

27-04-2026

yahoo.com

external link

Innate Pharma Q1 Earnings Call Highlights

13-05-2026

marketbeat.com

external link

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)

21-07-2026

yahoo.com

external link

Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference

23-07-2026

yahoo.com

external link

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) Sentiment Trend

0 25 50 75 100 3 12 77 79 69 57 66 90 55 66 06-11-2025 10-11-2025 26-11-2025 26-03-2026 27-03-2026 27-04-2026 13-05-2026 21-07-2026 23-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) FAQs

toggle

What is the current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is $1.7.


toggle

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) absolute price change since previous trading day?

The absolute price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is $-0.072.


toggle

INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) percentage price change since previous trading day?

The percentage price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is -4.0632%.


toggle

What is the most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is 57 out of 100.


toggle

What is the most recent average sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?

The most recent sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is .


SEC-8K** Filing Available For INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

PHAR (Pharming Group N.V. ADR)
AAPG (Ascentage Pharma Group Intl ADR)
AKTX (Akari Therapeutics ADR)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.